Salil Gandhi is a partner in Goodwin’s Technology + Life Sciences Group. Mr. Gandhi specializes in the representation of emerging growth companies throughout their lifecycles as well as venture capital funds and other private equity funds. For emerging companies, Mr. Gandhi advises on a variety of general corporate and governance issues, including corporate formation, venture capital financing and exit transactions. For venture capital and other strategic investors, he advises on structuring and executing investment transactions ranging from angel to control investments as well as portfolio dispositions. He also advises investors and companies in emerging markets, with a focus on India & South East Asia.